Conference Call Script Purdue Licensing and Collaboration Agreement August 3, 2009, 8:30 am Eastern TimeLicensing and Collaboration Agreement • August 3rd, 2009 • Transcept Pharmaceuticals Inc • Pharmaceutical preparations
Thank you Operator and good morning everyone. My name is Tom Soloway and I am the Chief Financial Officer of Transcept. Thank you for joining us today to discuss our recently signed License and Collaboration Agreement with Purdue Pharma for the commercialization of our lead product candidate, Intermezzo®, in the United States. Joining me on the call today is Glenn Oclassen, our President and Chief Executive Officer.
